Clinical trial
Prospective and Randomized Study of Fixed Versus Flexible Prophylactic Administration of Granulocyte Colony-Stimulating Factor (G-CSF) in Children With Cancer
NCT01987596 is registered in ClinicalTrials.gov with Barbara Ann Karmanos Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective and Randomized Study of Fixed Versus Flexible Prophylactic Administration of Granulocyte Colony-Stimulating Factor (G-CSF) in Children With Cancer
- Lead sponsor
- Barbara Ann Karmanos Cancer Institute
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- August 31, 2013
- Completion date
- June 30, 2018
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
childhood choroid plexus tumor, childhood medulloblastoma, childhood pineoblastoma, childhood soft tissue sarcoma, childhood supratentorial primitive neuroectodermal tumor, neuroblastoma, osteosarcoma, recurrent/refractory childhood hodgkin lymphoma, retinoblastoma, unspecified childhood solid tumor, protocol specific, wilms tumor and other childhood kidney tumors